Haohai Biotech: Repurchased 73,000 H shares on July 21, spending 1.2254 million Hong Kong dollars.

Haohai Life Sciences announced that on July 21, the company repurchased 73,000 H shares at a price of HK$16.64-16.88 per share, with a total price of HK$1,225,397. According to the share buyback authorization resolution passed on May 29, 2026, the company is authorized to repurchase a total of 3,478,034 shares. As of July 21, the company has repurchased 234,000 shares, accounting for 0.6728% of the shares issued on the day the resolution was passed. Following this share buyback, the temporary suspension period for the issuance of new shares or the sale or transfer of treasury shares will last until August 20, 2026.